Proceedings from the CIHLMU 5th Infectious Diseases Symposium 2016 “Drug Resistant Tuberculosis: Old Disease - New Challenge”

Abstract The 5th CIHLMU Infectious Disease Symposium, Munich, Germany, March 12, 2016 brought together Tuberculosis Experts from developed and low middle-income countries to discuss the control of drug resistance Tuberculosis. The meeting featured 9 presentations: Tuberculosis history and current sc...

Full description

Bibliographic Details
Main Authors: Celso Khosa, Krutarth Patel, Karlygash Abdiyeva, Nurkeldi Turebekov, Bettina Prüller, Norbert Heinrich
Format: Article
Language:English
Published: BMC 2017-09-01
Series:BMC Proceedings
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12919-017-0077-6
_version_ 1818180396243746816
author Celso Khosa
Krutarth Patel
Karlygash Abdiyeva
Nurkeldi Turebekov
Bettina Prüller
Norbert Heinrich
author_facet Celso Khosa
Krutarth Patel
Karlygash Abdiyeva
Nurkeldi Turebekov
Bettina Prüller
Norbert Heinrich
author_sort Celso Khosa
collection DOAJ
description Abstract The 5th CIHLMU Infectious Disease Symposium, Munich, Germany, March 12, 2016 brought together Tuberculosis Experts from developed and low middle-income countries to discuss the control of drug resistance Tuberculosis. The meeting featured 9 presentations: Tuberculosis history and current scenario, Tuberculosis and migration - current scenario in Germany, Mechanism of Tuberculosis resistance development, Epidemiology of resistance – transmission vs. new generation of resistance, The impact of diagnostic in patients beyond – sensitivity and specificity, The Bangladesh regimen – new hope trough old drugs, New drugs and regimens – an overview on studies and Multi and Extensively Drug Resistant Tuberculosis from Europe. The presentations were followed by a panel discussion. Serious Multidrug Resistance epidemic in some countries may jeopardize the progress in Tuberculosis control. In this meeting epidemiology, mechanism, immigration and screening, diagnosis, research and treatment of drug resistant tuberculosis were discussed.
first_indexed 2024-12-11T21:19:06Z
format Article
id doaj.art-71eb95623bf643b3acd387ef5ba65545
institution Directory Open Access Journal
issn 1753-6561
language English
last_indexed 2024-12-11T21:19:06Z
publishDate 2017-09-01
publisher BMC
record_format Article
series BMC Proceedings
spelling doaj.art-71eb95623bf643b3acd387ef5ba655452022-12-22T00:50:30ZengBMCBMC Proceedings1753-65612017-09-0111S101610.1186/s12919-017-0077-6Proceedings from the CIHLMU 5th Infectious Diseases Symposium 2016 “Drug Resistant Tuberculosis: Old Disease - New Challenge”Celso Khosa0Krutarth Patel1Karlygash Abdiyeva2Nurkeldi Turebekov3Bettina Prüller4Norbert Heinrich5Center for International Health – CIHLMUCenter for International Health – CIHLMUCenter for International Health – CIHLMUCenter for International Health – CIHLMUCenter for International Health – CIHLMUCenter for International Health – CIHLMUAbstract The 5th CIHLMU Infectious Disease Symposium, Munich, Germany, March 12, 2016 brought together Tuberculosis Experts from developed and low middle-income countries to discuss the control of drug resistance Tuberculosis. The meeting featured 9 presentations: Tuberculosis history and current scenario, Tuberculosis and migration - current scenario in Germany, Mechanism of Tuberculosis resistance development, Epidemiology of resistance – transmission vs. new generation of resistance, The impact of diagnostic in patients beyond – sensitivity and specificity, The Bangladesh regimen – new hope trough old drugs, New drugs and regimens – an overview on studies and Multi and Extensively Drug Resistant Tuberculosis from Europe. The presentations were followed by a panel discussion. Serious Multidrug Resistance epidemic in some countries may jeopardize the progress in Tuberculosis control. In this meeting epidemiology, mechanism, immigration and screening, diagnosis, research and treatment of drug resistant tuberculosis were discussed.http://link.springer.com/article/10.1186/s12919-017-0077-6Multi-drug resistant tuberculosisExtensively drug-resistant tuberculosisDiagnosisTherapy
spellingShingle Celso Khosa
Krutarth Patel
Karlygash Abdiyeva
Nurkeldi Turebekov
Bettina Prüller
Norbert Heinrich
Proceedings from the CIHLMU 5th Infectious Diseases Symposium 2016 “Drug Resistant Tuberculosis: Old Disease - New Challenge”
BMC Proceedings
Multi-drug resistant tuberculosis
Extensively drug-resistant tuberculosis
Diagnosis
Therapy
title Proceedings from the CIHLMU 5th Infectious Diseases Symposium 2016 “Drug Resistant Tuberculosis: Old Disease - New Challenge”
title_full Proceedings from the CIHLMU 5th Infectious Diseases Symposium 2016 “Drug Resistant Tuberculosis: Old Disease - New Challenge”
title_fullStr Proceedings from the CIHLMU 5th Infectious Diseases Symposium 2016 “Drug Resistant Tuberculosis: Old Disease - New Challenge”
title_full_unstemmed Proceedings from the CIHLMU 5th Infectious Diseases Symposium 2016 “Drug Resistant Tuberculosis: Old Disease - New Challenge”
title_short Proceedings from the CIHLMU 5th Infectious Diseases Symposium 2016 “Drug Resistant Tuberculosis: Old Disease - New Challenge”
title_sort proceedings from the cihlmu 5th infectious diseases symposium 2016 drug resistant tuberculosis old disease new challenge
topic Multi-drug resistant tuberculosis
Extensively drug-resistant tuberculosis
Diagnosis
Therapy
url http://link.springer.com/article/10.1186/s12919-017-0077-6
work_keys_str_mv AT celsokhosa proceedingsfromthecihlmu5thinfectiousdiseasessymposium2016drugresistanttuberculosisolddiseasenewchallenge
AT krutarthpatel proceedingsfromthecihlmu5thinfectiousdiseasessymposium2016drugresistanttuberculosisolddiseasenewchallenge
AT karlygashabdiyeva proceedingsfromthecihlmu5thinfectiousdiseasessymposium2016drugresistanttuberculosisolddiseasenewchallenge
AT nurkelditurebekov proceedingsfromthecihlmu5thinfectiousdiseasessymposium2016drugresistanttuberculosisolddiseasenewchallenge
AT bettinapruller proceedingsfromthecihlmu5thinfectiousdiseasessymposium2016drugresistanttuberculosisolddiseasenewchallenge
AT norbertheinrich proceedingsfromthecihlmu5thinfectiousdiseasessymposium2016drugresistanttuberculosisolddiseasenewchallenge